Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James R Rigas, MD
Norris Cotton Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
65 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Birmingham Hematology and Oncology Associates, Llc
Birmingham, Alabama, United States
- Oncology Specialties, P.C.
Huntsville, Alabama, United States
- Cooper Clinic
Fort Smith, Arkansas, United States
- Genesis Cancer Center
Hot Springs, Arkansas, United States
- Alta Bates Comprehensive Cancer Center
Berkeley, California, United States
- Northstate Cancer Speciality
Redding, California, United States
- Mercy General Hospital
Sacramento, California, United States
- St. Francis Hospital Cancer Center
Hartford, Connecticut, United States
- Connecticut Oncology Group
Middletown, Connecticut, United States
- George Bray Cancer Center/new Britain General Hospital
New Britain, Connecticut, United States
- Oncology and Hematology Associates, Pc
New London, Connecticut, United States
- Whittingham Cancer Center at Norwalk Hospital
Norwalk, Connecticut, United States
- Hematology/oncology Pc/carl and Dorothy Bennet Cancer Center
Stamford, Connecticut, United States
- Washington Cancer Institute
Washington D.C., District of Columbia, United States
- Pasco Hernando Oncology Associates
Brooksville, Florida, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Lee Cancer Clinic
Fort Myers, Florida, United States
- Jupiter Medical Center
Jupiter, Florida, United States
- Cancer Care of North Florida
Lake City, Florida, United States
- Pasco/hernando Oncology
New Port Richey, Florida, United States
- Mid Florida Oncology
Orange City, Florida, United States
- Md Anderson
Orlando, Florida, United States
- Oncology & Hematology Association of West Broward
Tamarac, Florida, United States
- Palm Beach Cancer Institute
West Palm Beach, Florida, United States
- Alexian Brothers Hospital Network
Elk Grove Village, Illinois, United States
- Joliet Hematology Associates
Joliet, Illinois, United States
- Investigative Clinical Research of Indiana Llc
Indianapolis, Indiana, United States
- Howard Regional Health System
Kokomo, Indiana, United States
- Mcfarland Clinic
Ames, Iowa, United States
- Kentucky Cancer Clinic
Hazard, Kentucky, United States
- Western Hematology Oncology
Paducah, Kentucky, United States
- Maine Center for Cancer Medicine
Scarborough, Maine, United States
- Franklin Square Hospital Center
Baltimore, Maryland, United States
- Harbor View Cancer Center
Baltimore, Maryland, United States
- Sinai Hospital of Baltimore
Baltimore, Maryland, United States
- Union Memorial Hospital
Baltimore, Maryland, United States
- Frederick Smith, Md
Chevy Chase, Maryland, United States
- Community Hematology Oncology
Olney, Maryland, United States
- Lahey Clinic Medical Center
Burlington, Massachusetts, United States
- Fallon Clinic Hematology/ Oncology
Worcester, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2005
- Primary completion
- 30 Apr 2014
- Completion
- 30 Apr 2014
- Last update posted
- 6 Sept 2019
- Registered enrollment
- 245
- Registry id
- NCT00153803
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.